New drug combo aims to beat tough leukemia
NCT ID NCT07211958
First seen Jun 25, 2026 · Last updated Jul 24, 2026 · Updated 3 times
Summary
This phase 3 trial tests whether adding the drug revumenib to standard intensive chemotherapy helps people with newly diagnosed acute myeloid leukemia (AML) that has a specific genetic change (NPM1 mutation). About 468 participants will receive either revumenib or a placebo along with chemotherapy. The study looks at how long people live without their cancer getting worse and if the cancer becomes undetectable.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- revumenib
- What this could lead to
- If it works, this could lead to a new treatment option that improves survival and reduces cancer cells for people with this type of AML.
- What could go wrong
- This is a large phase 3 trial, but it's still experimental. Adding revumenib may not improve outcomes and could cause additional side effects. Results are not guaranteed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA WITH NPM1 MUTATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Clinical Trial Site
RECRUITINGMelbourne, Victoria, 3004, Australia
-
Clinical Trial Site
RECRUITINGNedlands, Western Australia, 6009, Australia
-
Clinical Trial Site
RECRUITINGPerth, Western Australia, 6000, Australia
-
Clinical Trial Site
RECRUITINGGosford, 2250, Australia
-
Clinical Trial Site
RECRUITINGWollongong, 2500, Australia
-
Clinical Trial Site
RECRUITINGSankt Pölten, Lower Austria, 3100, Austria
-
Clinical Trial Site
RECRUITINGGraz, Styria, 8036, Austria
-
Clinical Trial Site
RECRUITINGLeoben, Styria, 8700, Austria
-
Clinical Trial Site
RECRUITINGLinz, 4030, Austria
-
Clinical Trial Site
RECRUITINGGhent, 9000, Belgium
-
Clinical Trial Site
RECRUITINGFortaleza, Paraná, 60430-372, Brazil
-
Clinical Trial Site
RECRUITINGBarretos, São Paulo, 14784-400, Brazil
-
Clinical Trial Site
RECRUITINGJaú, 17210-080, Brazil
-
Clinical Trial Site
RECRUITINGPorto Alegre, 90610-910, Brazil
-
Clinical Trial Site
RECRUITINGMontreal, H1T 2M4, Canada
-
Clinical Trial Site
RECRUITINGToronto, M5G 2C1, Canada
-
Clinical Trial Site
RECRUITINGAngers, Loire-Atlantique, 44093, France
-
Clinical Trial Site
RECRUITINGBayonne, 64100, France
-
Clinical Trial Site
RECRUITINGBordeaux, 33000, France
-
Clinical Trial Site
RECRUITINGBatumi, Adjara, 6000, Georgia
-
Clinical Trial Site
RECRUITINGTbilisi, 0112, Georgia
-
Clinical Trial Site
RECRUITINGTbilisi, 0186, Georgia
-
Clinical Trial Site
RECRUITINGTübingen, Baden-Wurttemberg, 72076, Germany
-
Clinical Trial Site
RECRUITINGDüsseldorf, North Rhine-Westphalia, 40479, Germany
-
Clinical Trial Site
RECRUITINGHerne, North Rhine-Westphalia, 44625, Germany
-
Clinical Trial Site
RECRUITINGJena, Thuringia, 07747, Germany
-
Clinical Trial Site
RECRUITINGHamburg, 20251, Germany
-
Clinical Trial Site
RECRUITINGGyőr, Gyor-Moson-Sopron Varmegye, H-9024, Hungary
-
Clinical Trial Site
RECRUITINGPetah Tikva, Central District, 4941492, Israel
-
Clinical Trial Site
RECRUITINGTel Aviv, Tel Aviv, 6423906, Israel
-
Clinical Trial Site
RECRUITINGHaifa, 3109601, Israel
-
Clinical Trial Site
RECRUITINGJerusalem, 91031, Israel
-
Clinical Trial Site
RECRUITINGJerusalem, 91120, Israel
-
Clinical Trial Site
RECRUITINGMonza, Monza E Brianza, 20900, Italy
-
Clinical Trial Site
RECRUITINGAlessandria, 15121, Italy
-
Clinical Trial Site
RECRUITINGBergamo, 24127, Italy
-
Clinical Trial Site
RECRUITINGBologna, 40138, Italy
-
Clinical Trial Site
RECRUITINGCandiolo, 10060, Italy
-
Clinical Trial Site
RECRUITINGFlorence, 50134, Italy
-
Clinical Trial Site
RECRUITINGMeldola, 40-47014, Italy
-
Clinical Trial Site
RECRUITINGMilan, 20141, Italy
-
Clinical Trial Site
RECRUITINGMilan, 60-20132, Italy
-
Clinical Trial Site
RECRUITINGPalermo, 90146, Italy
-
Clinical Trial Site
RECRUITINGPavia, 19-27100, Italy
-
Clinical Trial Site
RECRUITINGPerugia, 06132, Italy
-
Clinical Trial Site
RECRUITINGRimini, 47923, Italy
-
Clinical Trial Site
RECRUITINGRoma, 00168, Italy
-
Clinical Trial Site
RECRUITINGUdine, 15-33100, Italy
-
Clinical Trial Site
RECRUITINGJohor Bahru, Johor, 80000, Malaysia
-
Clinical Trial Site
RECRUITINGPetaling Jaya, 46050, Malaysia
-
Clinical Trial Site
RECRUITINGSubang Jaya, 46150, Malaysia
-
Clinical Trial Site
RECRUITINGTârgu Mureş, Mureș County, 540136, Romania
-
Clinical Trial Site
RECRUITINGBucharest, 020125, Romania
-
Clinical Trial Site
RECRUITINGBucharest, 030171, Romania
-
Clinical Trial Site
RECRUITINGCluj-Napoca, 400015, Romania
-
Clinical Trial Site
RECRUITINGIași, 700483, Romania
-
Clinical Trial Site
RECRUITINGBusan, Busan Gwang'yeogsi [Pusan-Kwangyokshi], 49201, South Korea
-
Clinical Trial Site
RECRUITINGBusan, 48108, South Korea
-
Clinical Trial Site
RECRUITINGGoyang-si, 10408, South Korea
-
Clinical Trial Site
RECRUITINGSeoul, 03080, South Korea
-
Clinical Trial Site
RECRUITINGSeoul, 06591, South Korea
-
Clinical Trial Site
RECRUITINGLas Palmas de Gran Canaria, Canary Islands, 35010, Spain
-
Clinical Trial Site
RECRUITINGOviedo, Principality of Asturias, 33011, Spain
-
Clinical Trial Site
RECRUITINGBadalona, 08916, Spain
-
Clinical Trial Site
RECRUITINGBarcelona, 08036, Spain
-
Clinical Trial Site
RECRUITINGBurgos, 09006, Spain
-
Clinical Trial Site
RECRUITINGCáceres, 10003, Spain
-
Clinical Trial Site
RECRUITINGGranada, 18014, Spain
-
Clinical Trial Site
RECRUITINGMadrid, 28007, Spain
-
Clinical Trial Site
RECRUITINGMadrid, 28033, Spain
-
Clinical Trial Site
RECRUITINGMadrid, 28034, Spain
-
Clinical Trial Site
RECRUITINGMálaga, 29010, Spain
-
Clinical Trial Site
RECRUITINGPalma, 07120, Spain
-
Clinical Trial Site
RECRUITINGPamplona, 31008, Spain
-
Clinical Trial Site
RECRUITINGSeville, 41013, Spain
-
Clinical Trial Site
RECRUITINGValencia, 46026, Spain
-
Clinical Trial Site
RECRUITINGAberdeen, AB25 2ZN, United Kingdom
-
Clinical Trial Site
RECRUITINGDerby, DE22 3NE, United Kingdom
-
Clinical Trial Site
RECRUITINGLincoln, LN2 4AX, United Kingdom
-
Clinical Trial Site
RECRUITINGLondon, W12 0HS, United Kingdom
-
Clinical Trial Site
RECRUITINGSutton, SM2 5PT, United Kingdom
-
Clinical Trial Site 1
RECRUITINGTbilisi, 0159, Georgia
-
Clinical Trial Site 2
RECRUITINGTbilisi, 0159, Georgia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New combo therapy targets Hard-to-Cure leukemia
- New hope for tough blood cancers: first human trial launches
- New pill could boost leukemia treatment for patients with specific gene changes
- New pill targets Leukemia's genetic weakness in patients too sick for chemo
- New hope for Hard-to-Treat leukemia: targeted pill combined with chemotherapy enters human trials
- Promising new combo targets hard-to-treat leukemia mutations